2023
Internal and Environmental Predictors of Physician Practice Use of Screening and Medications for Opioid Use Disorders
Miller-Rosales C, Busch S, Meara E, King A, D’Aunno T, Colla C. Internal and Environmental Predictors of Physician Practice Use of Screening and Medications for Opioid Use Disorders. Medical Care Research And Review 2023, 80: 410-422. PMID: 37036056, PMCID: PMC10949918, DOI: 10.1177/10775587231162681.Peer-Reviewed Original ResearchMeSH KeywordsAnalgesics, OpioidBuprenorphineHumansOpiate Substitution TreatmentOpioid-Related DisordersPhysiciansConceptsOngoing opioid epidemicOpioid use disorderOpioid useUse disordersHealth information technology functionalityAvailability of MOUDPrimary careOpioid epidemicMOUDMultispecialty practicePhysician practicesMedicationsBehavioral cliniciansDemonstrated effectivenessDisordersPractice useScreeningCliniciansCare
2022
Physician response to COVID-19-driven telehealth flexibility for opioid use disorder.
Beetham T, Fiellin DA, Busch SH. Physician response to COVID-19-driven telehealth flexibility for opioid use disorder. The American Journal Of Managed Care 2022, 28: 456-463. PMID: 36121359, DOI: 10.37765/ajmc.2022.89221.Peer-Reviewed Original ResearchMeSH KeywordsBuprenorphineCOVID-19HumansOpioid-Related DisordersPandemicsPhysiciansRetrospective StudiesTelemedicineUnited StatesConceptsOpioid use disorder treatmentCOVID-19 pandemicEarly COVID-19 eraOpioid use disorderUse disorder treatmentOUD treatmentTelehealth useUse disordersPhysician responsesTelehealth effectivenessDisorder treatmentTelehealth technologyPhysiciansTelehealthCOVID-19 eraTelehealth regulationsCOVID-19Administrative dataMost respondentsTreatmentRetrospective usePandemicSurvey participationPerceptions of effectivenessRespondents' use
2015
Emergency Department–Initiated Buprenorphine/Naloxone Treatment for Opioid Dependence: A Randomized Clinical Trial
D’Onofrio G, O’Connor P, Pantalon MV, Chawarski MC, Busch SH, Owens PH, Bernstein SL, Fiellin DA. Emergency Department–Initiated Buprenorphine/Naloxone Treatment for Opioid Dependence: A Randomized Clinical Trial. JAMA 2015, 313: 1636-1644. PMID: 25919527, PMCID: PMC4527523, DOI: 10.1001/jama.2015.3474.Peer-Reviewed Original ResearchConceptsBrief intervention groupOpioid-dependent patientsIllicit opioid useAddiction treatment servicesPercent of patientsBuprenorphine groupEmergency departmentIntervention groupReferral groupOpioid useTreatment servicesBrief interventionOpioid dependenceClinical trialsHIV riskUrban teaching hospital emergency departmentBuprenorphine/naloxone treatmentHuman immunodeficiency virus (HIV) riskTeaching hospital emergency departmentAddiction treatmentBuprenorphine treatment groupUrine samplesBuprenorphine/naloxoneRandomized clinical trialsCommunity-based treatment services